Investing

By Will Feuer Regeneron Pharmaceuticals said the Food and Drug Administration has approved an eight-milligram injection of its Eylea treatment…

As contrarian investors, we have no desire to buy the stock market while it’s hot. We wait for it to…

By Will Feuer Palo Alto Networks reported a jump in earnings for its fiscal fourth quarter and issued upbeat guidance…

Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed…

The most aggressive Federal Reserve rate-hiking campaign in decades crushed the bond market in 2022, sending the iShares Core U.S.…

When looking for juicy yields, investors these days should stay short. Buying long-dated Treasury bonds seemed like a great opportunity…

Facebook users have less than a week left to opt in to part of a $725 million class action settlement…

It’s no secret that the world’s business and policymaking establishment adopted carbon penalties and offsets as a climate-change mitigation approach…

Call it a “Barbie” bonanza: Margot Robbie, the star of the blockbuster film, is in line for a $50 million…

Consumer goods giant Unilever PLC is coming under renewed pressure to exit Russia following recent comments from the company’s CEO…